These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34209046)

  • 1. The METTL3-m
    Maldonado López A; Capell BC
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34209046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
    Petri BJ; Klinge CM
    J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
    He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
    J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted Roles of the
    Hu C; Liu J; Li Y; Jiang W; Ji D; Liu W; Ma T
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human m
    Wang X; Huang J; Zou T; Yin P
    RNA Biol; 2017 Mar; 14(3):300-304. PubMed ID: 28121234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
    mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Roles of RNA m
    Lan Q; Liu PY; Bell JL; Wang JY; Hüttelmaier S; Zhang XD; Zhang L; Liu T
    Cancer Res; 2021 Jul; 81(13):3431-3440. PubMed ID: 34228629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m
    Yen YP; Chen JA
    J Biomed Sci; 2021 May; 28(1):40. PubMed ID: 34039354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
    Meyer KD; Jaffrey SR
    Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of METTL3 in cancer: mechanisms and therapeutic targeting.
    Zeng C; Huang W; Li Y; Weng H
    J Hematol Oncol; 2020 Aug; 13(1):117. PubMed ID: 32854717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection and functions of RNA modification m
    Zhang W; Qian Y; Jia G
    J Biol Chem; 2021 Aug; 297(2):100973. PubMed ID: 34280435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
    Haran V; Lenka N
    Stem Cell Rev Rep; 2019 Aug; 15(4):474-496. PubMed ID: 31123982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3-dependent N
    Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-mediated m6A modification is required for cerebellar development.
    Wang CX; Cui GS; Liu X; Xu K; Wang M; Zhang XX; Jiang LY; Li A; Yang Y; Lai WY; Sun BF; Jiang GB; Wang HL; Tong WM; Li W; Wang XJ; Yang YG; Zhou Q
    PLoS Biol; 2018 Jun; 16(6):e2004880. PubMed ID: 29879109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 Is Involved in the Development of Graves' Disease by Inducing SOCS mRNA m6A Modification.
    Song RH; Du P; Gao CQ; Liu XR; Zhang JA
    Front Endocrinol (Lausanne); 2021; 12():666393. PubMed ID: 34616359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.